Policy Seminar: What Does the Fall of ‘Chevron’ Deference Mean for Health Policy?

12:00pm - 1:00pm • Steinberg-Dietrich Hall, Room 213, 3620 Locust Walk

2024-10-16 12:00:00 2024-10-16 13:00:00 America/New_York Policy Seminar: What Does the Fall of ‘Chevron’ Deference Mean for Health Policy? What Does the Fall of ‘Chevron’ Deference Mean for Health Policy? A Conversation with Allison Hoffman, JD, Holly Fernandez-Lynch, JD, MBE, and Kate Shaw, JD, moderated by Julia Hinckley, JD Open to Penn affiliates In Person event October 16, 2024 12:00PM - 1:00Pm ET Steinberg-Dietrich Hall, Room 213, 3620 Locust Walk, Philadelphia, PA In its 2024 term, the U.S. Supreme Court overturned a 40-year-old precedent directing federal courts to defer to agency interpretations of ambiguous statutes. Because Congress often leaves such ambiguity in its laws relevant to health and health care, the Court’s decision is likely to have a substantial impact on health policy. What should we expect now? LDI’s expert panel will unpack that question, explaining the Supreme Court’s modern approach to administrative law and its implications for the work of the Centers for Medicare and Medicaid Services (CMS), the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), and other agencies focused on health. Co-hosted with the Department of Medical Ethics & Health Policy and the University of Pennsylvania Carey Law School. Please note: In-person attendance at this event is preferred. Virtual access will be provided to registrants who are unable to be on campus. Speakers Alison Hoffman, JD Professor, Law, Penn Carey Law School Holly Fernandez-Lynch, JD, MBE Associate Professor, Medical Ethics and Health Policy, Perelman School of Medicine; Associate Professor, Law, Penn Carey Law School Kate Shaw, JD Professor, Law, Penn Carey Law School Julia Hinckley, JD Director, Policy Strategy, Penn LDI Steinberg-Dietrich Hall, Room 213, 3620 Locust Walk Penn Medical Ethics

In its 2024 term, the U.S. Supreme Court overturned a 40-year-old precedent directing federal courts to defer to agency interpretations of ambiguous statutes. Because Congress often leaves such ambiguity in its laws relevant to health and health care, the Court’s decision is likely to have a substantial impact on health policy. What should we expect now? LDI’s expert panel will unpack that question, explaining the Supreme Court’s modern approach to administrative law and its implications for the work of the Centers for Medicare and Medicaid Services (CMS), the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), and other agencies focused on health.

Co-hosted with the Department of Medical Ethics & Health Policy and the University of Pennsylvania Carey Law School.

Please note: In-person attendance at this event is preferred. Virtual access will be provided to registrants who are unable to be on campus.